	Non-pharmacological interventions for anxiety and depression in Parkinson's disease. Cochrane Database Syst Rev Li T, Shi J, Zheng Q, Xu JG, Zhang M, Ren Y, Zhang B, Li Z. PMID: 42339755 [PubMed - in process]
	Melatonin supplementation as an adjunct to dual-task training: effects on functional capacity and quality of life in Parkinson's disease. Int J Food Sci Nutr Ben Yahia M, Jallouli S, Romdhani M, Ammar A, Ben Hamed K, Kallela MS, Farhat N, Moalla KS, Damak M, Termoz N, Driss T, Hammouda O. PMID: 42339752 [PubMed - as supplied by publisher]
	Therapeutic management of osteoporosis in Parkinson's disease. Expert Opin Pharmacother Toussirot E, Compagne C, Sagawa Y, Bereau M. PMID: 42339684 [PubMed - as supplied by publisher]
	Parkinson's disease beyond motor symptoms: a review of the validity and limitations of current classification of non-motor symptoms. Front Psychiatry Makhani A, Mestre TA, Abe AM. PMID: 42338732 [PubMed]
	Development of a rapid and simple Xeno Nucleic Acid (XNA) sensor-based microRNA detection platform for Parkinson's disease diagnostics. J Nanobiotechnology Byun MY, Ryu MY, Chung SJ, Lee B, Oh JR, Woo JK, Shin JY, Han MK, Bang OY, Kim YJ, Kuo MC, Lin-Wang HH, Wu RM, Lin SP, Cho SK, Lee PH, Yang SW. PMID: 42337584 [PubMed - as supplied by publisher]
	Primary prevention of Parkinson's disease: proceedings, the 8C's and a position statement from the Parkinson's disease prevention think tank. NPJ Parkinsons Dis Mantri S, Au R, Barnes A, Beck JC, Blake K, Borum P, Dahl W, de Miranda B, Dorsey ER, Fang R, Fenn JD, Goldie SJ, Goldman SM, Gonzalez-Latapi P, Guarin DL, Kryzyzanowski B, Lessard N, Lipstein Fristedt A, Mehta TR, Norcini M, Purks JL, Schiehser D, Schwarzschild MA, Tanner CM, Temkin A, Unruh JB, Vulpe C, Wallock K, Walz C, Willis AW, Okun MS. PMID: 42336841 [PubMed - as supplied by publisher]
	Evolution of Voice Characteristics in People with Parkinson's Disease: A Five Year Follow-Up. J Voice Cabrera GJ, Farías P, Sáez CG. PMID: 42336738 [PubMed - as supplied by publisher]
	Convergent imaging and genetic signatures of gray matter atrophy in Parkinson's disease. Neuroimage Xie Y, Dong Z, Jiang Y, Lin S, Wang X, Sun J, Zhang N, Zhang Z, Du J, Liu H, Cao D. PMID: 42336304 [PubMed - as supplied by publisher]
	Shared genetic architecture of Parkinson's disease and cutaneous melanoma: Heterogeneous pleiotropy and Colocalization at the SOX6 locus. Prog Neuropsychopharmacol Biol Psychiatry Li C, Baur A, Pan L. PMID: 42335983 [PubMed - as supplied by publisher]
	Loneliness and mood symptoms in Parkinson's disease: An item-level network analysis. Parkinsonism Relat Disord McDaniels B, Zhou K, Mischley LK, Subramanian I. PMID: 42335825 [PubMed - as supplied by publisher]
	Personalised prediction of institutionalisation in Parkinson's: prognostic factor identification and model development and validation using IPD meta-analysis. Parkinsonism Relat Disord Li Y, McLernon DJ, Lawson RA, Yarnall AJ, Bäckström D, Forsgren L, Camacho M, Williams-Gray CH, Maple-Grødem J, Alves G, Tysnes OB, Counsell CE, Macleod AD, Parkinson's Incidence Cohorts Collaboration. PMID: 42335823 [PubMed - as supplied by publisher]
	Bacoside-A from Bacopa monnieri (L.) Wettst. in Parkinson's disease: In Silico and preclinical insights into dopaminergic neuroprotection. Biomed Pharmacother Dadhich A, Verma AK, Dhar I, Bhatt S, Agarwal N, Sharma MM. PMID: 42335514 [PubMed - as supplied by publisher]
	Usability of Levodopa Cyclops(Â®) Compared to INBRIJA(Â®) During an off Episode in Parkinson's Disease Patients. J Aerosol Med Pulm Drug Deliv Wangsawirana V, de Jong L, Meulen AV, Hagedoorn P, Luinstra M, Frijlink HW. PMID: 42334368 [PubMed - as supplied by publisher]
	Basal ganglia neurophysiological markers of non-motor symptoms in Parkinson's disease: A systematic review. J Parkinsons Dis Keulen BJ, Beudel M, Malekzadeh A, de Bie RM, Swinnen BE. PMID: 42334335 [PubMed - as supplied by publisher]
	Mapping the Parkinson's pandemic: Unveiling and addressing the global burden. J Parkinsons Dis Shalash A, Schumacher-Schuh AF, Salama M, Noyce A, Ha ULN, Chew Seng Tan L, Tanner CM. PMID: 42334224 [PubMed - as supplied by publisher]
	Physical activity and exercise participation-Impact on motor and non-motor outcomes in early-stage Parkinson disease: A cross-sectional study. PM R Thrue C, Bonde-Jensen F, Hvid LG, Dalgas U, Langeskov-Christensen M. PMID: 42332367 [PubMed - as supplied by publisher]
	Iranian Deep Brain Stimulation Registry for Parkinson's Disease (IDBSR-PD): establishment and feasibility study. Acta Neurol Belg Abdollahifard S, Maghsoodzadeh S, Rezaei R, Najibi A, Heidarian A, Haghighi MM, Khademi F, Sabet S, Torabzade-Tari S, Karimi A, Razmkon A, Jaafari N. PMID: 42332325 [PubMed - as supplied by publisher]
	Expression of Concern: Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial. Lancet The Editors Of The Lancet. PMID: 42330995 [PubMed - as supplied by publisher]
	Efficacy of the voice-activated intelligent personal assistant (VIPA) intervention on psychosocial well-being among people with Parkinson's disease: A pilot randomized controlled trial. Parkinsonism Relat Disord Lau TK, Leung AYM. PMID: 42330833 [PubMed - as supplied by publisher]
	Association between CHRNA5 polymorphisms and Parkinson's disease in Northern Chinese Han population: a case-control study. Ann Hum Biol Xian W, Sun X, Wang Y, Sun X, Zhang J, Qin K, Zhou Y, He Q, Li Y, Xie A, Hou B. PMID: 42329050 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 57883

Page 1 of 2895



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy